Day One Biopharmaceuticals, Inc.
DAWN
$6.76
$0.467.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.08M | -95.50M | -84.29M | -167.48M | -208.94M |
| Total Depreciation and Amortization | 2.81M | 2.03M | 1.37M | 726.00K | 410.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.87M | -11.13M | -10.10M | -65.32M | 34.77M |
| Change in Net Operating Assets | -7.24M | 26.48M | 3.55M | 54.78M | 3.16M |
| Cash from Operations | -87.38M | -78.11M | -89.48M | -177.29M | -170.60M |
| Capital Expenditure | -2.49M | -2.17M | -758.00K | -75.00K | -198.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -350.41M | -228.83M | 69.78M | 225.72M | 229.06M |
| Cash from Investing | -352.90M | -230.99M | 69.03M | 225.64M | 228.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 182.30M | 182.35M | 181.10M | 2.06M | 162.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 20.94M | 20.94M | 20.94M | -- | -- |
| Cash from Financing | 203.24M | 203.29M | 202.04M | 2.06M | 162.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.03M | -105.82M | 181.59M | 50.41M | 221.12M |